Literature DB >> 26561750

Cerium oxide for the destruction of chemical warfare agents: A comparison of synthetic routes.

Pavel Janoš1, Jiří Henych2, Ondřej Pelant3, Věra Pilařová3, Luboš Vrtoch3, Martin Kormunda4, Karel Mazanec5, Václav Štengl6.   

Abstract

Four different synthetic routes were used to prepare active forms of cerium oxide that are capable of destroying toxic organophosphates: a sol-gel process (via a citrate precursor), homogeneous hydrolysis and a precipitation/calcination procedure (via carbonate and oxalate precursors). The samples prepared via homogeneous hydrolysis with urea and the samples prepared via precipitation with ammonium bicarbonate (with subsequent calcination at 500°C in both cases) exhibited the highest degradation efficiencies towards the extremely dangerous nerve agents soman (O-pinacolyl methylphosphonofluoridate) and VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate) and the organophosphate pesticide parathion methyl. These samples were able to destroy more than 90% of the toxic compounds in less than 10 min. The high degradation efficiency of cerium oxide is related to its complex surface chemistry (presence of surface OH groups and surface non-stoichiometry) and to its nanocrystalline nature, which promotes the formation of crystal defects on which the decomposition of organophosphates proceeds through a nucleophilic substitution mechanism that is not dissimilar to the mechanism of enzymatic hydrolysis of organic phosphates by phosphotriesterase.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerium oxide; Chemical warfare agents; Decontamination; Organophosphate compounds

Year:  2015        PMID: 26561750     DOI: 10.1016/j.jhazmat.2015.10.069

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

1.  Amidoxime-functionalized bead cellulose for the decomposition of highly toxic organophosphates.

Authors:  Pavel Janoš; Oldřich Tokar; Marek Došek; Karel Mazanec; Petr Ryšánek; Martin Kormunda; Jiří Henych; Pavel Janoš
Journal:  RSC Adv       Date:  2021-05-18       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.